Treatment with nasal neuro-EPO improves the neurological, cognitive, and histological state in a gerbil model of focal ischemia

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 2288-2300

  Rodríguez Cruz, Yamila ^a   Mengana Támos, Yuneidys ^b   Muñoz Cernuda, Adriana ^c   Subirós Martines, Nelvis ^d   González Quevedo, Alina ^d   Sosa Testé, Iliana ^b   García Rodríguez, Julio César ^e  

^a Histology Department   (Cuba)

^b Biomodels Unit   (Cuba)

^c CENTRO DE INVESTIGACIÓN Y DESARROLLO DE MEDICAMENTOS CIDEM   (Cuba)

^d INSTITUTO DE NEUROLOGÍA Y NEUROCIRUGÍA   (Cuba)

^e National Center for Laboratory Animal Breeding (CENPALAB)   (Cuba)

Author keywords

EPO; Gerbils; Ischemia; Nasal route; Neuro EPO; Neuroprotection; Stroke

Indexed keywords

ERYTHROPOIETIN; IOR; NEURO ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; SIALIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN ISCHEMIA; COGNITION; CONTROLLED STUDY; GERBIL; HISTOLOGY; MALE; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; STROKE; SURVIVAL; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ANIMALS; BRAIN; BRAIN ISCHEMIA; COGNITION; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; GERBILLINAE; HUMANS; MALE; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; TREATMENT OUTCOME;

ANIMALIA; GERBILLINAE;

EID: 78650300712     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.215     Document Type: Article

References (61)

1. MINSAP (2003) Anuario Estadistico de Salud en Cuba. Available from www.infomed.sld.cu/servicios/estadisticas/
2. Ovbiagele, B., Kidwell, C.S., Starkman, S., and Saber, J.L. (2003) Neuroprotective agents for the treatment of acute ischemic stroke. Curr. Neurol. Neurosci. Rep. 3, 9-20.
3. Lipton, P. (1999) Ischemic cell death in brain neurons. Physiol. Rev. 79(4), 1431-568.
4. Siren, A.L., Fasshauer, T., Bartels, C., and Ehrenreich, H. (2009) Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 6(1), 108-127.
5. DeBow, S.B., Clark, D.L., Maclellan, C.L., and Colbourne, F. (2003) Incomplete assessment of experimental cytoprotectants in rodent ischemia studies. Can. J. Neurol. Sci. 30(4), 368-374.
6. García Salman, J.D. (2004) Protección neuronal endógena: un enfoque alternativo. Rev. Neurol. 38(2), 150-155.
7. Dirnagl, U., Simon, R.P., and Hallenbeck, J.M. (2003) Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 26(5), 248-254.
8. Jelkmann, W. (2004) Molecular biology of erythropoietin. Intern. Med. 43, 649-659.
9. Kalialis, L.V. and Olsen, N.V. (2003) Erythropoietin--a new therapy in cerebral ischemia? Ugeskr. Laeger 165, 2477.
10. Eid, T. and Brines, M. (2002) Recombinant human erythropoietin for neuroprotection: what is the evidence? Clin. Breast Cancer Suppl 3, 109-115.
11. Marti, H.H., Bernaudin, M., Petit, E., and Bauer, C. (2000) Neuroprotection and angiogenesis: dual role of erythropoietin in brain ischemia. News Physiol. Sci. 15(5), 225-229.
12. Lipšic, E., Schoemaker, R.G., van der Meer, P., Voors, A.A., van Veldhuisen, D., and van Gilst, W.H. (2006) Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. J. Am. Coll. Cardiol. 48(11), 2161-2167.
13. Bernaudin, M., Marti, H.H., Roussel, S., et al. (1999) A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19(6), 643-651.
14. Siren, A.L., Fratelli, M., Brines, M., et al. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 98(7), 4044-4049.
15. Wang, L., Zhang, Z., Wang, Y., Zhang, R., and Chopp, M. (2004) Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35(7), 1732-1737. (Pubitemid 38823656)
16. Garcia Rodriguez, J.C. and Sosa Teste, I. (2009) The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans. TheScientificWorldJOURNAL 9, 970-981.
17. Yamashita, T., Nonoguchi, N., Ikemoto, T., Miyatake, S., and Kuroiwa, T. (2010) Asialoerythropoietin attenuates neuronal cell death in the hippocampal CA1 region after transient forebrain ischemia in a gerbil model. Neurol. Res. 32(9), 957-962.
18. Hermann, D.M. (2009) Enhancing the delivery of erythropoietin and its variants into the ischemic brain. TheScientificWorldJOURNAL 9, 967-969.
19. Hanson, L.R. and Frey, W.H. (2008) Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 9(Suppl 3), S5.
20. Pathan, S.A., Iqbal, Z., Zaidi, S.M., et al. (2009) CNS drug delivery systems: novel approaches. Recent Pat. Drug Deliv. Formul. 3(1), 71-89.
21. Fletcher, L., Kohli, S., Sprague, S.M., et al. (2009) Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. J. Neurosurg. 111(1), 164-170.
22. Thorne, R.G., Pronk, G.J., Padmanabhan, V., and Frey, W.H. (2004) Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127(2), 481-496.
23. Sosa, I., Cruz, J., Santana, J., et al. (2007) Paso de la molécula de eritropoyetina humana recombinante con bajo contenido de ácido siálico al Sistema nervioso central por la vía intranasal en los modelos del meriones unguiculatus y el primate no humano Macaca fascicularis. Rev. Salud Anim. 29(2), 1-6.
24. Subiros Martínez, N., García Rodríguez, J.C., González Navarro, B., Sosa, I., and García Salman, J.D. (2005) Evaluación histológica del efecto de la Eritropoyetina vía intranasal, sobre la muerte neuronal retardada en gerbos sometidos a isquemia cerebral transitoria. Estudio preliminar. 7° Congreso Virtual Hispanoamericano de Anatomía Patológica 2005. Available from www.conganat.org/7congreso/445.pdf
25. Yu, Y.-P., Xu, Q.-Q., Zhang, Q., Zhang, W.-P., Zhang, L.-H., and Wei, E.-Q. (2005) Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia. Neurosci. Lett. 387, 5-10.
26. CCAC (1993) Guide to the Care and Use of Experimental Animals. 2nd ed. Canadian Council on Animal Care, Ontario, Canada. 211 p.
27. Sosa, I., García Rodríguez, J.C., Santana, J., et al. (2006) Intranasal administration of recombinant human erythropoietin exerts neuroprotective effects on post-ischemic brain injury in Mongolian gerbils. PharmacologyOnline 1, 100-112.
28. Butterfield, J.D. and McGraw, C.P. (1978) Effect of the DPPD (diphenyl-para-phenylendiamine) on stroke and cerebral edema in gerbils. Stroke 9(5), 480-483.
29. Lawner, P., Laurent, J., Simeone, F., Fink, E., and Rubin, E. (1979) Attenuation of ischemic brain edema by pentobarbital after carotid ligation in the gerbil. Stroke 10(6), 644-647. (Pubitemid 10203454)
30. Loskota, W.J., Lomax, P., and Verity, M.A. (1973) A Stereotaxic Atlas of the Mongolian Gerbil Brain (Meriones unguiculatus). Ann Arbor Science, Los Angeles.
31. Illum, L. (2002) Nasal drug delivery: new developments and strategies. Drug Discov. Today 7(23), 1184-1189.
32. Pardridge, W.M. (2007) Blood-brain barrier delivery. Drug Discov. Today 12(1-2), 54-61.
33. Faure, S., Oudart, N., Javellaud, J., Fournier, A., Warnock, D., and Achard, J. (2006) Synergistic protective effects of erythropoietin and olmesartan on ischemic stroke survival and post-stroke memory dysfunctions in the gerbil. J. Hypertens. 24(11), 2255-2261.
34. Wen, T.C., Sadamoto, Y., Tanaka, J., et al. (2002) Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression. J. Neurosci. Res. 67(6), 795-803. (Pubitemid 34226292)
35. Lapchak, P.A. (2010) Erythropoietin molecules to treat acute ischemic stroke: a translational dilemma! Expert Opin. Investig. Drugs 19(10), 1179-1186.
36. Catania, M.A., Marciano, M.C., Parisi, A., et al. (2002) Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. Eur. J. Pharmacol. 437(3), 147-150. (Pubitemid 34219475)
37. Sadamoto, Y., Igase, K., Sakanaka, M., et al. (1998) Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem. Biophys. Res. Commun. 253, 26-32.
38. Nuñez, Y., Bueno, P.V., Carrillo, D.C., et al. (2009) Neuroprotective effect of a nasal formulation of erythropoietin with low sialic acid content. Rev. Cubana Farm. 43(1), 1-13.
39. Kirino, T. (1982) Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239(1), 57-69.
40. Sosa, I., García Salman, J.D., Rodríguez, Y., Subiros, N., Rodríguez, K., and Thomas, A. (2007) Sensibilidad de los modelos de isquemia global y focal en el gerbil de Mongolia. Available from www.Ilustrados.com:EyFpAVAlpCfBOoWnY
41. Sosa, I., Mengana, T.Y., García, S.J.D., et al. (2008) Recombinant human erythropoietin as a neuroprotective therapy in brain ischemia. Biotecnol. Apl. 25, 223-229.
42. Brines, M.L. and Cerami, A. (2008) Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J. Intern. Med. 264(5), 405-432.
43. Ghezzi, P. and Brines, M. (2004) Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ.11(Suppl 1), S37-44.
44. Mattson, M.P., Culmsee, C., and Yu, Z.F. (2000) Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res. 301, 173-187.
45. Yang, X.F., Xiong, J.W., Wang, Z.L., et al. (2009) [Mechanism of inhibition of apoptosis of human umbilical vein endothelial cells induced by oxidized-low density lipoprotein by erythropoietin]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 21(11), 656-659.
46. Agnello, D., Bigini, P., Villa, P., et al. (2002) Erythropoietin exerts anti-inflammatory effect on the CNS in a model of experimental autoinmune encephalomyelitis. Brain Res. 952, 128-134. (Pubitemid 35279495)
47. Whitehead, S.N., Hachinski, V.C., and Cechetto, D.F. (2005) Interaction between a rat model of cerebral ischemia and beta-amyloid toxicity: inflammatory responses. Stroke 36, 107-112.
48. Arcasoy, M.O. (2008) The non-haematopoietic biological effects of erythropoietin. Br. J. Haematol. 141(1), 14-31.
49. Brines, M.L. and Cerami, A. (2006) Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney Int. 70(2), 246-250.
50. Buemi, M., Galeano, M., Sturiale, A., et al. (2004) Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds. Shock 22(2), 169-173. (Pubitemid 40228196)
51. Li Y, Lu Z, Keogh CL, Yu SP, and Wei L. (2007) Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab May;27(5), 1043-54.
52. Liu, S.P., Lee, S.D., Lee, H.T., et al. (2010) Granulocyte colony-stimulating factor activating HIF-1alpha acts synergistically with erythropoietin to promote tissue plasticity. PLoS One 5(4), e10093.
53. Castillo, J., Varez-Sabin, J., Davalos, A., et al. (2003) [Consensus review. Pharmacological neuroprotection in cerebral ischemia: is it still a therapeutic option?]. Neurologia Sep;18(7), 368-384.
54. Chan, P.H. (2001) Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab.21(1), 2-14.
55. Ikeda, K., Negishi, H., and Yamori, Y. (2003) Antioxidant nutrients and hypoxia/ischemia brain injury in rodents. Toxicology 189(1-2), 55-61.
56. Margaill, I., Plotkine, M., and Lerouet, D. (2005) Antioxidant strategies in the treatment of stroke. Free Radic. Biol. Med. 39(4), 429-443.
57. Phan, T.G., Wright, P.M., Markus, R., Howells, D.W., Davis, S.M., and Donnan, G.A. (2002) Salvage the ischaemic penumbra: more than just reperfusion? Clin. Exp. Pharmacol. 29, 1-10.
58. Shingo, T., Sorokan, S.T., Shimazaki, T., and Weiss, S. (2001) Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J. Neurosci. 21(24), 9733-9743.
59. Kirino, T. and Sano, K. (1984) Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol. (Berl.) 62(3), 201-208. (Pubitemid 14178596)
60. Payan, H.M. and Conrad, J.R. (1977) Carotid ligation in gerbils. Influence of age, sex, and gonads. Stroke 8(2), 194-196.
61. Torup, L. and Leist, M. (2006) Development of non-erythropoietic erythropoietin variants for neuroprotection. In Erythropoietin and the Nervous System. Höke, A., Ed. Springer, New York.